Bioregenx (BRGX) Net Equity Issued and Repurchased (2023)
Bioregenx's (BRGX) quarterly Net Equity Issued and Repurchased came in at $527088.0 in Q4 2023, up 733.88% quarter-over-quarter from $63209.0 in Q3 2023.
Bioregenx (BRGX) Net Equity Issued and Repurchased (2023) Analysis & Trends
Bioregenx's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $527088.0 for Q4 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $527088.0 in Q4 2023; TTM through Sep 2024 was $527088.0, a N/A change from a year earlier, with the FY2023 full-year figure at $1.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $527088.0 in Q4 2023 per BRGX's latest filing, from $63209.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $527088.0 in Q4 2023 and bottomed at $63209.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | - |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | - |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | - |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 527,088.00 |
| Dec 31, 2023 | 527,088.00 |
| Sep 30, 2023 | 63,209.00 |
| Sep 30, 2023 | 63,209.00 |
| Jun 30, 2023 | 414,105.00 |
| Jun 30, 2023 | 414,105.00 |
| Mar 31, 2023 | 337,739.00 |
| Mar 31, 2023 | 337,739.00 |